Salta al contenuto principale
Passa alla visualizzazione normale.

Ricerca avanzata per:

Risultati della ricerca

  • 1. Seminari del Dottorato di ricerca in BIOMEDICINA E NEUROSCIENZE (100%)

    9-mag-2016 9.00.24

    Seminari del Dottorato di ricerca in BIOMEDICINA E NEUROSCIENZE bionec, dottorato, Biomedicina, Neuroscienze, fulvestrant, anticancer therapy, YopH, Yersinia pestis Mercoledì 11 Maggio 2016 a partire dalle ore 14:00 nell’aula Nesci della Sezione di Anatomia del Dipartimento BioNeC (presso il Policlinico Universitario), si terranno due seminari organizzati nell’ambito delle attività didattiche ... (2-methoxyestradiol, fulvestrant) and polyphenols of olive oil in anticancer therapy". - Dr

  • 2. SEMINAR_5-11-2016 (80%)

    6-mag-2016 8.58.43

    oil in anticancer therapy

  • 3. cv prof. daniele santini (39%)

    14-apr-2022 16.41.15

  • 4. CV_CONCETTA_GIANCOLA (30%)

    17-apr-2020 12.00.54

    -drug recognition in anticancer therapy”. Current Cancer Drug Targets (2007), 7(6), 520-540 ... , Barone G, Giancola C. “Quadruplex-forming oligonucleotides as tools in anticancer therapy and

  • 5. giancola_cv (30%)

    22-apr-2020 14.19.47

    in anticancer therapy” Current Cancer Drug Targets (2007), 7, 520-540. 55. Virno A, Randazzo ... oligonucleotides as tools in anticancer therapy and aptamers design: Energetic aspects” Current

  • 6. cv prof. giancola (30%)

    14-apr-2022 16.51.45

    oligonucleotides as tools in anticancer therapy and aptamers design: Energetic aspects” Current Medicinal ... ), 16048-16056. 54. Pagano B, Giancola C*. “Energetics of quadruplex-drug recognition in anticancer therapy” Current Cancer Drug Targets (2007), 7, 520-540. 55. Virno A, Randazzo A, Giancola C

  • 7. Progetti di ricerca (30%)

    26-feb-2024 18.20.03

    -quadruplex DNA binders for targeted anticancer therapy BARONE Giampaolo 12509 2015-NAZ-0018 NAZ_ALTRO ... CALVARUSO Giuseppe 11049 2014-PICO-0022 PICO_OTHER 2014 Smart Anticancer Therapy: design of new DNA

  • 8. biosketch_alcaro_jan_19 (24%)

    10-apr-2020 10.33.26

    Grant FIRB on the project "New agents in the specific anticancer therapy". Role: PI

  • 9. Progetti di Ricerca 2015 (24%)

    26-apr-2021 15.33.45

    anticancer therapy BARONE Giampaolo 12509 2015-NAZ-0018 NAZ_ALTRO 2015 DRUG DELIVERY: VEICOLI

  • 10. Progetti di Ricerca 2014 (24%)

    26-apr-2021 15.35.29

    Anticancer Therapy: design of new DNA G-quadruplex stabilizers and their delivery by Receptor-targeted

  • 11. Esiti - Verbale n. 1 del 01.02.2021 (24%)

    5-feb-2021 9.09.14

    for metal complexes in anticancer therapy” – MultiAct - Responsabile Scientifico UNIPA, Prof

  • 12. Progetti di Ricerca 2015 (24%)

    6-mar-2017 15.35.27

    anticancer therapy BARONE Giampaolo 12509 2015-NAZ-0018 NAZ_ALTRO 2015 DRUG DELIVERY: VEICOLI

  • 13. Progetti di Ricerca 2014 (24%)

    6-mar-2017 15.43.19

    Anticancer Therapy: design of new DNA G-quadruplex stabilizers and their delivery by Receptor-targeted

  • 14. cv_santillo (24%)

    31-mag-2023 11.02.37

    pathway of cholesterol and isoprenoids in human colorectal cancer: pathway inhibitors in anticancer therapy.” funded from Ministry of Health, 2000/2001 ADDITIONAL INFORMATION Projects

  • 15. l1-cv-galizia (21%)

    16-apr-2020 10.35.00

    Therapeutics Drugs European Journal of Surgical Oncology Expert Review of Anticancer Therapy Expert

  • 16. stefano_alcaro_may_17 (21%)

    7-nov-2017 14.22.33

    in the specific anticancer therapy". Role: PI of local unit 2009 Grant MIUR on the project "

  • 17. cv 2023 Carreca Anna Paola (21%)

    28-mar-2023 15.24.54

    , Expert Review of Anticancer Therapy, 15:3, 317-330, DOI: 10.1586/14737140.2015.992785, Im pact Factor

  • 18. Trial clinici (21%)

    27-lug-2023 10.48.43

    levels. Targeting the IGF system is therefore a promising anticancer therapy and a new tool

  • 19. Trial clinici (21%)

    25-lug-2023 12.34.14

    is therefore a promising anticancer therapy and a new tool for oncologists. Evidence from bio-gerontology

  • 20. cv prof. nicolai (17%)

    6-apr-2022 11.17.34

    Head & Neck  European Journal of Cancer  Expert Review of Anticancer Therapy  Head and